Yamaguchi, O., Kaira, K., Hashimoto, K., Mouri, A., Shiono, A., Miura, Y., . . . Kuji, I. (2020). Tumor metabolic volume by (18)F-FDG-PET as a prognostic predictor of first-line pembrolizumab for NSCLC patients with PD-L1 ≥ 50%. Sci Rep.
Citação norma ChicagoYamaguchi, Ou, et al. "Tumor Metabolic Volume By (18)F-FDG-PET As a Prognostic Predictor of First-line Pembrolizumab for NSCLC Patients With PD-L1 ≥ 50%." Sci Rep 2020.
Citação norma MLAYamaguchi, Ou, et al. "Tumor Metabolic Volume By (18)F-FDG-PET As a Prognostic Predictor of First-line Pembrolizumab for NSCLC Patients With PD-L1 ≥ 50%." Sci Rep 2020.
Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.